Amrutanjan Health Care Limited (NSE:AMRUTANJAN) — Market Cap & Net Worth
Market Cap & Net Worth: Amrutanjan Health Care Limited (AMRUTANJAN)
Amrutanjan Health Care Limited (NSE:AMRUTANJAN) has a market capitalization of $154.33 Million (Rs14.27 Billion) as of September 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #17644 globally and #941 in its home market, demonstrating a -2.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amrutanjan Health Care Limited's stock price Rs493.80 by its total outstanding shares 28900081 (28.90 Million). Also see Amrutanjan Health Care Limited total assets for a full breakdown of the balance sheet.
Amrutanjan Health Care Limited Market Cap History: 2015 to 2026
Amrutanjan Health Care Limited's market capitalization history from 2015 to 2026. Data shows growth from $70.58 Million to $154.33 Million (8.02% CAGR). Also see AMRUTANJAN operating cash flow for how efficiently the company converts equity into cash flow.
Amrutanjan Health Care Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amrutanjan Health Care Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check AMRUTANJAN stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.05x
Amrutanjan Health Care Limited's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.41x
Amrutanjan Health Care Limited's market cap is 0.41 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $78.47 Million | $1.87 Billion | $205.76 Million | 0.04x | 0.38x |
| 2017 | $97.13 Million | $2.22 Billion | $214.09 Million | 0.04x | 0.45x |
| 2018 | $87.24 Million | $2.22 Billion | $199.73 Million | 0.04x | 0.44x |
| 2019 | $133.48 Million | $2.52 Billion | $245.14 Million | 0.05x | 0.54x |
| 2020 | $152.95 Million | $2.61 Billion | $250.83 Million | 0.06x | 0.61x |
| 2021 | $286.96 Million | $3.32 Billion | $611.90 Million | 0.09x | 0.47x |
| 2022 | $219.07 Million | $4.05 Billion | $671.89 Million | 0.05x | 0.33x |
| 2023 | $186.19 Million | $3.80 Billion | $398.35 Million | 0.05x | 0.47x |
| 2024 | $225.86 Million | $4.21 Billion | $449.73 Million | 0.05x | 0.50x |
| 2025 | $208.95 Million | $4.51 Billion | $508.35 Million | 0.05x | 0.41x |
Competitor Companies of AMRUTANJAN by Market Capitalization
Companies near Amrutanjan Health Care Limited in the global market cap rankings as of September 19, 2026. Review tangible net worth ratio of Amrutanjan Health Care Limited to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Amrutanjan Health Care Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Amrutanjan Health Care Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Amrutanjan Health Care Limited's market cap moved from $70.58 Million to $ 154.33 Million, with a yearly change of 8.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs154.33 Million | -26.14% |
| 2025 | Rs208.95 Million | -7.49% |
| 2024 | Rs225.86 Million | +21.31% |
| 2023 | Rs186.19 Million | -15.01% |
| 2022 | Rs219.07 Million | -23.66% |
| 2021 | Rs286.96 Million | +87.62% |
| 2020 | Rs152.95 Million | +14.58% |
| 2019 | Rs133.48 Million | +53.01% |
| 2018 | Rs87.24 Million | -10.19% |
| 2017 | Rs97.13 Million | +23.78% |
| 2016 | Rs78.47 Million | +11.17% |
| 2015 | Rs70.58 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Amrutanjan Health Care Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $154.33 Million USD |
| MoneyControl | $154.33 Million USD |
| MarketWatch | $154.33 Million USD |
| marketcap.company | $154.33 Million USD |
| Reuters | $154.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Amrutanjan Health Care Limited
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn co… Read more